|
CA2416527C
(en)
|
2000-08-10 |
2009-12-22 |
Pharmacia Italia S.P.A. |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
EP1863810A4
(en)
|
2005-03-22 |
2010-03-31 |
Astrazeneca Ab |
NEW TETRAHYDRO-1H-PYRIDO [4,3-B] INDOLDERIVATE AS CB1 'RECEPTOR LIGANDS
|
|
FR2884252B1
(fr)
|
2005-04-08 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives d'isoindoles, compositions les contenant, leur preparation et leurs utilisations pharmaceutiques notamment en tant qu'inhibiteurs d'activites de la proteine chaperone hsp90
|
|
AR058223A1
(es)
|
2005-11-25 |
2008-01-23 |
Palau Pharma Sa |
Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto
|
|
EP2223925A1
(en)
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
HUE052510T2
(hu)
|
2009-05-27 |
2021-05-28 |
Ptc Therapeutics Inc |
Módszerek a rák és a nem daganatos állapotok kezelésére
|
|
WO2010138695A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating neurofibromatosis
|
|
WO2010138659A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating brain tumors
|
|
EP3205648A1
(en)
|
2010-06-10 |
2017-08-16 |
Seragon Pharmaceuticals, Inc. |
Estrogen receptor modulators and uses thereof
|
|
US8853423B2
(en)
|
2010-06-17 |
2014-10-07 |
Seragon Pharmaceuticals, Inc. |
Indane estrogen receptor modulators and uses thereof
|
|
EP2791132A4
(en)
|
2011-12-14 |
2015-08-05 |
Seragon Pharmaceuticals Inc |
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
|
|
US10987334B2
(en)
*
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
|
EP3733170A1
(en)
|
2012-07-13 |
2020-11-04 |
Oncternal Therapeutics, Inc. |
A method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms)
|
|
AP2015008858A0
(en)
|
2013-05-28 |
2015-11-30 |
Astrazeneca Ab |
Chemical compounds
|
|
BR112015030595A2
(pt)
|
2013-06-19 |
2017-07-25 |
Seragon Pharmaceuticals Inc |
moduladores de receptor de estrogênio de azetidina e usos dos mesmos
|
|
EA031077B1
(ru)
|
2013-06-19 |
2018-11-30 |
Серагон Фармасьютикалз, Инк. |
Модулятор рецептора эстрогена и его применения
|
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
|
WO2016097071A1
(en)
|
2014-12-18 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Estrogen receptor modulators and uses thereof
|
|
TWI784255B
(zh)
|
2014-12-18 |
2022-11-21 |
瑞士商赫孚孟拉羅股份公司 |
四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途
|
|
CN107406433A
(zh)
|
2014-12-18 |
2017-11-28 |
豪夫迈·罗氏有限公司 |
用于治疗癌症的2,3‑二苯基色烯的衍生物
|
|
WO2016174551A1
(en)
|
2015-04-27 |
2016-11-03 |
Pfizer Inc. |
Anti-estrogenic compounds
|
|
MX384605B
(es)
|
2015-04-29 |
2025-03-14 |
Radius Pharmaceuticals Inc |
Combinación de palbociclib y rad1901 para usarse en el tratamiento de cáncer de mama en un sujeto con cáncer positivo a receptor de estrógeno.
|
|
JP6768711B2
(ja)
|
2015-05-26 |
2020-10-14 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
複素環式エストロゲン受容体モジュレーター及びその使用
|
|
EP3312184A4
(en)
|
2015-06-16 |
2019-02-27 |
Jiangsu Hengrui Medicine Co., Ltd. |
PIPERIDINE DERIVATIVE AND ITS PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF
|
|
CN106518768B
(zh)
|
2015-09-15 |
2021-07-02 |
江苏恒瑞医药股份有限公司 |
丙烯酸类衍生物、其制备方法及其在医药上的应用
|
|
WO2017059139A1
(en)
|
2015-10-01 |
2017-04-06 |
Olema Pharmaceuticals, Inc. |
TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
|
|
JP6920295B2
(ja)
|
2015-11-09 |
2021-08-18 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
テトラヒドロナフタレンエストロゲン受容体モジュレーター及びその使用
|
|
EP3378861B1
(en)
|
2015-11-12 |
2021-08-04 |
Zhejiang Hisun Pharmaceutical Co., Ltd. |
Acrylic acid derivative, preparation method and use in medicine thereof
|
|
WO2017107754A1
(zh)
|
2015-12-22 |
2017-06-29 |
江苏恒瑞医药股份有限公司 |
苯并哌啶类衍生物、其制备方法及其在医药上的应用
|
|
WO2017160990A1
(en)
|
2016-03-15 |
2017-09-21 |
Merrimack Pharmaceuticals, Inc. |
Methods for treating er+, her2-, hrg+ breast cancer using combination therapies comprising an anti-erbb3 antibody
|
|
EP3440067B1
(en)
|
2016-04-08 |
2021-05-26 |
F. Hoffmann-La Roche AG |
Tetrahydroisoquinoline estrogen receptor modulators and uses thereof
|
|
TW201803870A
(zh)
|
2016-04-20 |
2018-02-01 |
阿斯特捷利康公司 |
化學化合物
|
|
WO2017192991A1
(en)
|
2016-05-06 |
2017-11-09 |
Xavier University Of Louisiana |
Selective estrogen receptor down-regulators (serds)
|
|
WO2018001232A1
(zh)
|
2016-06-29 |
2018-01-04 |
浙江海正药业股份有限公司 |
丙烯酸类衍生物及其制备方法和其在医药上的用途
|
|
US10149839B2
(en)
|
2016-07-25 |
2018-12-11 |
Astrazeneca Ab |
Chemical compounds
|
|
CN107814798B
(zh)
|
2016-09-14 |
2020-11-03 |
四川科伦博泰生物医药股份有限公司 |
3-取代丙烯酸类化合物及其制备方法和用途
|
|
EP3512842B1
(en)
|
2016-09-15 |
2024-01-17 |
Arvinas, Inc. |
Indole derivatives as estrogen receptor degraders
|
|
UA125824C2
(uk)
|
2016-10-24 |
2022-06-15 |
Астразенека Аб |
6,7,8,9-ТЕТРАГІДРО-3H-ПІРАЗОЛО[4,3-f]ІЗОХІНОЛІНОВІ ПОХІДНІ, ЗАСТОСОВНІ В ЛІКУВАННІ РАКУ
|
|
BR102016024814A2
(pt)
|
2016-10-24 |
2018-05-08 |
Aché Laboratórios Farmacêuticos S.A. |
composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
|
|
WO2018109607A1
(en)
|
2016-12-16 |
2018-06-21 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
US20200077658A1
(en)
|
2016-12-16 |
2020-03-12 |
Basf Se |
Pesticidal Compounds
|
|
JOP20190144A1
(ar)
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
|
TWI831738B
(zh)
|
2016-12-16 |
2024-02-11 |
美商瑞塔醫藥有限責任公司 |
用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
|
|
MX2022004474A
(es)
|
2016-12-16 |
2023-08-15 |
Janssen Pharmaceutica Nv |
Inhibidores de moléculas pequeñas de la familia de quinasas jak.
|
|
JP6793836B2
(ja)
|
2016-12-16 |
2020-12-02 |
イーライ リリー アンド カンパニー |
変異体idh1およびidh2阻害剤としての7−フェニルエチルアミノ−4h−ピリミド[4,5−d][1,3]オキサジン−2−オン化合物
|
|
AR110782A1
(es)
|
2017-01-30 |
2019-05-02 |
Chiesi Farm Spa |
Derivados de tirosinamida como inhibidores de rho-quinasa
|